APA (7th ed.) Citation

Karakas, M., Friede, T., Butler, J., Talha, K. M., Placzek, M., Asendorf, T., . . . Anker, S. (2025). Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes. European journal of heart failure, 27(11), . https://doi.org/10.1002/ejhf.3742

Chicago Style (17th ed.) Citation

Karakas, Mahir, et al. "Intravenous Ferric Carboxymaltose in Heart Failure with Iron Deficiency (FAIR-HF2 DZHK05 Trial): Sex-specific Outcomes." European Journal of Heart Failure 27, no. 11 (2025). https://doi.org/10.1002/ejhf.3742.

MLA (9th ed.) Citation

Karakas, Mahir, et al. "Intravenous Ferric Carboxymaltose in Heart Failure with Iron Deficiency (FAIR-HF2 DZHK05 Trial): Sex-specific Outcomes." European Journal of Heart Failure, vol. 27, no. 11, 2025, https://doi.org/10.1002/ejhf.3742.